Cell Cryopreservation Global Market Report 2024

The cell cryopreservation market size has grown exponentially in recent years. It will grow from $10.21 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The growth during the historic period is driven by several factors, including the rising demand for cell-based therapies, increased focus on biomedical research, growing necessity for organ transplantation, heightened R&D efforts in cell-based therapies, and the expanding utilization of cryopreserved cells.

The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $29.9 billion in 2028 at a compound annual growth rate (CAGR) of 24%. In the forecast period, growth is fueled by several factors, increased demand for in vitro fertilization (IVF) procedures, advancements in organ transplantation techniques, expanding biobanking activities, a rise in chronic disease cases, and supportive government initiatives and funding. Major trends during this period encompass advancements in cryopreservation techniques, MRNA vaccine storage and transportation improvements, enhancements in cryoprotectants and freezing methods, a growing inclination towards personalized medicine, and progress in stem cell research.

The growth of the cell cryopreservation market is anticipated to be driven by the increasing number of organ transplantation procedures. Organ transplantation involves replacing damaged or failing organs with healthy ones from donors, a procedure on the rise due to factors such as organ failure from various causes such as hereditary abnormalities, infections, traumas, and chronic diseases. In the context of organ transplantation, cell cryopreservation plays a vital role by freezing and storing cells from organs, preserving their viability for future use, improving graft success rates, and reducing immune rejection. For instance, data from the Health Resources and Services Administration in January 2024 showed a significant increase in organ transplants performed in 2023 compared to previous years, highlighting the upward trend in organ transplantation that fuels the demand for cell cryopreservation.

Companies in the cell cryopreservation market are focusing on developing advanced cryopreservation medium solutions to meet evolving customer needs. Cryopreservation medium solutions are specialized formulations that freeze cells or tissues at ultra-low temperatures, enabling long-term storage and transport while maintaining their viability and functionality. For example, Pluristyx Inc., a US-based provider of tools and technologies for cellular therapies, recently introduced PluriFreeze, a proprietary cryopreservation medium solution designed to accelerate the development of stem cell therapies. PluriFreeze is specifically tailored to support the growth of induced pluripotent stem cells (iPSCs), offering a novel approach to enhance the efficiency and quality of iPSC therapy development, particularly in stem cell therapy research and commercialization.

In December 2021, CooperSurgical Inc., a US-based medical equipment manufacturer, acquired Generate Life Sciences for $1.6 billion. This acquisition strengthened CooperSurgical's position in serving fertility clinics, obstetricians, and gynecologists by expanding its product and service offerings in cell cryopreservation. Generate Life Sciences, known for its expertise in cell cryopreservation services, brought valuable capabilities and a strong clinical reputation to CooperSurgical's portfolio.

Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited.

North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell cryopreservation involves cooling cells to sub-zero temperatures, typically in liquid nitrogen at -196°C, to preserve them. This process stops all biological activity and metabolism, enabling cells to be stored for extended periods without deterioration. Cryoprotective agents are essential to prevent ice crystal formation, which could harm cell structures during freezing and thawing.

The primary products of cell cryopreservation include cell freezing media, equipment, and consumables. Equipment comprises specialized tools such as controlled-rate freezing apparatuses or isopropanol chambers designed to freeze cells at specific rates. This technology finds applications in preserving various cell types such as hepatocytes, stem cells, oocytes, embryotic cells, sperm cells, among others. These products reach end-users through channels such as biopharmaceutical and pharmaceutical companies, research institutes, Biobanks, in vitro fertilization (IVF) clinics, and similar entities.

The cell cryopreservation market research report is one of a series of new reports that provides cell cryopreservation market statistics, including the cell cryopreservation industry global market size, regional shares, competitors with cell cryopreservation market share, detailed cell cryopreservation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. These cell cryopreservation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.